In an effort to better understand the access challenges across the US, Hims & Hers introduced the GLP-1 Supply Tracker to help more individuals share their experiences and use their voice to ensure the FDA has the information it needs to better support accessible care
For those dealing with immune challenges or seeking to optimize immune function, this product provides oral access to a peptide with substantial clinical backing
Loomba R et al., SYNERGY-NASH, NEJM 2024 (NEJMoa2401943, PMID 38856224) : tirzepatide and MASH, resolution in 62% at the 15 mg level
The Nuanced Science of Subcutaneous Delivery To really appreciate why subcutaneous is the go-to route, we need to look a bit closer at the physiology
Visible particles, flakes, or floating material indicate structural breakdown of the peptide
In addition, experimental studies have shown that the elevation of GSH can inhibit the activation of hepatic stellate cells [33], which is a key driving factor for extracellular matrix deposition and fibrosis, thereby preventing the progression of liver fibrosis [34]